Trademark Overview
On Friday, January 17, 2025, a trademark application was filed for XENTRIA with the United States Patent and Trademark Office. The USPTO has given the XENTRIA trademark a serial number of 99007883. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 8, 2025. This trademark is owned by Xentria, Inc.. The XENTRIA trademark is filed in the Pharmaceutical Products category with the following description:
house mark for a full line of biologic, biosimilar, and pharmaceutical preparations; house mark for a full line of biologics; house mark for a full line of biosimilars; house mark for a full line of pharmaceuticals; house mark for a full line of biologic, biosimilar, and pharmaceutical products; biologic, biosimilar, and pharmaceutical preparations for the treatment of bone disease; biologic, biosimilar, and pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; biologic, biosimilar, and pharmaceutical preparations for the treatment of diabetes; biologic, biosimilar, and pharmaceutical preparations for treatment and prevention of autoimmune diseases and autoimmune disorders; biologic, biosimilar, and pharmaceutical oncology preparations; anti-inflammatories; biologic, biosimilar, and pharmaceutical preparations for the treatment of immune system related diseases and disorders; biologic, biosimila...
